Institutional investors purchased a net $1.3 million shares of MDCO during the quarter ended March 2016 and now own 119.17% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ADDISON CAPITAL CO. Bought 16.3 Thousand shares of Medicines Co
BNP PARIBAS ARBITRAGE SNC Bought 11.5 Thousand shares of Medicines Co
SIMPLEX TRADING LLC Bought 8.5 Thousand shares of Medicines Co